ʻO Resveratrol

Anter

• E kūpono paha no ...
• ʻAʻole kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Resveratrol kahi kemika i loaʻa i loko o ka waina ʻulaʻula, nā ʻili hua waina ʻulaʻula, wai wai huaʻalani poni, mulberry, a me nā mea liʻiliʻi i nā pī. Hoʻohana ʻia ia ma ke ʻano he lāʻau.

Hoʻohana pinepine ʻia ʻo Resveratrol no ke kolesterol kiʻekiʻe, maʻi ʻaʻai, maʻi puʻuwai, a me nā ʻano ʻē aʻe he nui. Eia nō naʻe, ʻaʻohe hōʻike ikaika e kākoʻo ai i ka hoʻohana o resveratrol no kēia mau hoʻohana.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no RESVERATROL penei:

E kūpono paha no ...

• Ke kunu wela. Ke hoʻohana nei i kahi ehu ihu i loaʻa ka resveratrol ʻekolu manawa i kēlā me kēia lā no 4 mau pule e hoʻoliʻiliʻi i nā ʻōuli o nā maʻi āpau i nā mākua me nā manawa āpau. ʻO ka hoʻohana ʻana i ka ehu ihal i loko o resveratrol a me beta-glucans ʻekolu manawa i kēlā me kēia lā no 2 mau mahina e like me ka hōʻemi ʻana i nā hōʻailona maʻi āpau i nā keiki me nā maʻi kūlohelohe.
• Ka momona. Hōʻike kekahi noiʻi e hiki i ka lawe ʻana i resveratrol ke hoʻonui i ka pohō kaumaha i nā mākua obese.

ʻAʻole kūpono paha no ...

• Maʻi maʻi puʻuwai. ʻO ka poʻe e ʻai i ka nui o ka resveratrol papaʻai ʻaʻohe o lākou haʻahaʻa haʻahaʻa o ka maʻi puʻuwai ke hoʻohālikelike ʻia me ka poʻe e ʻai i nā mea haʻahaʻa. Eia kekahi, ʻo ka lawe ʻana i ka resveratrol e ka waha, ʻaʻole ia e hoʻomaikaʻi i nā kiʻekiʻe o ke kōkō a i ʻole nā ​​momona o ke koko i kapa ʻia he triglycerides i ka poʻe i makaʻu no ka maʻi puʻuwai.
• ʻO kahi hui o nā hōʻailona e hoʻonui i ka makaʻi o ka maʻi kō, ka maʻi puʻuwai, a me ka hahau (metabolic syndrome). ʻO ka lawe ʻana i resveratrol me he mea lā ʻaʻole ia e hoʻohaʻahaʻa i ke kahe o ke koko, ke kō i ke kō, a i ʻole ka cholesterol i ka poʻe me ka maʻi metabolic. Hōʻike ka noiʻi mua e kōkua paha ka resveratrol e hōʻemi i ke kaumaha o ke kino a me ka momona o ke kino i ka poʻe me ka maʻi metabolic. Akā pono nā noiʻi hou e hōʻoia.
• Kūkulu i ka momona i ke akepaʻa i ka poʻe inu inu liʻiliʻi a ʻaole paha i ka wai ʻona (nonalcoholic fatty fat disease or NAFLD). ʻO ka hapa nui o nā noiʻi mua e hōʻike nei ʻaʻole hoʻomaikaʻi ka resveratrol i ka hana o ke ake, ka scarring ate, a me nā pae kolesterol i ka poʻe me NAFLD.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Huehue. Hōʻike ka noiʻi mua i ka noi ʻana i kahi gel i resveratrol i ka maka no 60 mau lā e hoʻēmi i ka nui o ka huehue.
• E hōʻole i ka hoʻomanaʻo a me nā mākau noʻonoʻo e hana maʻamau me ka makahiki. ʻAʻole maopopo inā kōkua ka resveratrol i ka hoʻomanaʻo a i ʻole ka noʻonoʻo ʻana i ka poʻe kahiko. Hōʻike kekahi o nā noiʻi mua e hoʻomaikaʻi paha ka resveratrol i nā mākau noʻonoʻo a me ka hoʻomanaʻo ʻana i nā wahine ma hope o ka menopause. Akā hōʻike ʻia kahi noiʻi ʻē aʻe i ka resveratrol i hāʻawi ʻia i nā ʻoi kiʻekiʻe a i ʻole no ka manawa lōʻihi ʻaʻole hoʻomaikaʻi i ka hoʻomanaʻo a i ʻole ka noʻonoʻo ʻana i nā mākua olakino olakino.
• ʻO kahi maʻi koko e hōʻemi i nā pae o ka protein i loko o ke koko i kapa ʻia hemoglobin (beta-thalassemia). Hōʻike ka noiʻi mua i ka lawe ʻana i trans-resveratrol ʻaʻole ia e hoʻomaikaʻi i nā pae hemoglobin a i ʻole ka pono o ke kō koko ʻana i ka poʻe me ka beta-thalassemia.
• Kanesa. ʻO ka poʻe e ʻai i ka nui o ka resveratrol papaʻai ʻaʻohe o lākou haʻahaʻa haʻahaʻa o ka maʻi ʻaʻai ke hoʻohālikelike ʻia i ka poʻe e ʻai i nā mea haʻahaʻa.
• Diabetes. Hōʻike kekahi noiʻi e hoʻomaikaʻi ka resveratrol i ke kaohi kō kō i nā poʻe me ka maʻi kō. Akā ʻaʻole hōʻike ka noiʻi ʻē aʻe i kahi pōmaikaʻi. Hiki paha i Resveratrol ke kōkua i ka hoʻohaʻahaʻa ʻana i ke kō i ke kō i nā mea maʻi wale nō me nā pae kō kō e mālama ʻole ʻia. Pono e noiʻi hou e hōʻoia.
• Nā hōʻino kīwaha i ka poʻe me ka maʻi diabetes (diabetic nephropathy). Hōʻike ka noiʻi mua i ka lawe ʻana i resveratrol me ka losartan lāʻau hiki ke hoʻomaikaʻi i kekahi mau ana o ka hōʻino ʻana o ka puʻupaʻa i ka poʻe me ka nephropathy diabetic.
• ʻO kahi maʻi māmā e ʻoi aku ai ka paʻakikī i ka hanu ʻana (maʻi pulmonary ākea ākea a COPD paha). Hōʻike ka noiʻi mua i ka lawe ʻana i kahi huahana hui pū me resveratrol, wikamina C, zinc, a me flavonoids e hoʻoliʻiliʻi iki ai i ka hana a me ka hana mucus i nā poʻe me COPD. Akā ʻaʻole maopopo inā loaʻa ka pōmaikaʻi ma muli o resveratrol a i ʻole nā ​​mea hoʻohui ʻē aʻe.
• ʻO Osteoarthritis. Hōʻike ka noiʻi mua i ka hoʻohui ʻana i resveratrol i nā ʻano maʻamau no ka osteoarthritis kuli e hoʻomaikaʻi ai i ka ʻeha, ka hana, a me ke ʻoʻoleʻa ma mua o nā maʻamau maʻamau wale nō.
• ʻO ka hoʻomaikaʻi ʻana i kahi hana lapaʻau i kapa ʻia he dialysis peritoneal. Hōʻike ka noiʻi mua e hiki i ka resveratrol ke holo wikiwiki i ka kānana koko i ka poʻe e loaʻa ana i ka dialysis peritoneal.
• ʻO kahi maʻi hormonal nāna e hoʻonui i nā ovaries me nā cist (polycystic ovary syndrome a i ʻole PCOS). Hōʻike kahi noiʻi mua e hoʻemi ana ka resveratrol testosterone i nā wahine me PCOS. Akā ʻaʻole ia e hoʻomaikaʻi i ke kaupaona, pae lipid, huehue, a me ka ulu lauoho makemake ʻole ʻia i nā wahine me kēia ʻano.
• Rheumatoid arthritis (RA). Lawe i ka resveratrol me nā lāʻau no RA me he mea lā e hōʻemi ana i ka nui o nā hono ʻeha a pehu. Akā ʻaʻole ʻike ʻia inā kōkua ka resveratrol i ka hōʻemi ʻana i nā pōʻino ami.
• ʻO kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis). Hōʻike ka noiʻi mua i resveratrol e hoʻomaikaʻi i nā hōʻailona a hoʻemi i ka hana o ulcerative colitis.
• ʻIli ʻili.
• E hōʻole i ka hoʻomanaʻo a me ka noʻonoʻo noʻonoʻo i ka poʻe kahiko ʻoi aku ma mua o ka mea maʻamau no ko lākou mau makahiki.
• ʻO ka paʻakikī o nā aʻa (atherosclerosis).
• Nā mākau hoʻomanaʻo a me ka noʻonoʻo (function cognitive).
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i resveratrol no kēia mau hoʻohana.

Hoʻonui paha ʻo Resveratrol i nā kīʻaha koko a hoʻēmi i ka hana o nā hunaola nui i ka paʻa ʻana o ke koko. Hōʻike kekahi noiʻi e loaʻa i ka resveratrol nāwaliwali estrogen (kahi wahine wahine) hopena. Hiki iā ia ke hoʻemi i ka ʻeha a me ka pehu ʻana. Hiki i ka Resveratrol ke hoʻoliʻiliʻi i nā kiʻekiʻe o ke kō (glucose) i loko o ke koko a kōkua i ke kino e kūʻē i nā maʻi. Hiki iā ia ke pale i nā protein i ka lolo mai ka pili pū ʻana e kōkua i ka pale ʻana i nā maʻi e like me ka maʻi ʻo Alzheimer.

Ke lawe ʻia e ka waha: ʻO Resveratrol ʻo ia LIKELY SAFE ke hoʻohana ʻia i nā nui i loaʻa i nā meaʻai. Ke lawe ʻia i nā kaha a i ka 1500 mg i kēlā me kēia lā a i nā mahina 3, resveratrol SAFE MAU PONO. Hoʻohana palekana ʻia nā kiʻekiʻena kiʻekiʻe a hiki i 2000-3000 mg i kēlā me kēia lā no 2-6 mau mahina. Eia nō naʻe, ʻoi aku ka nui o kēia mau lāʻau kiʻekiʻe o resveratrol i nā pilikia o ka ʻōpū.

Ke hoʻopili ʻia i ka ʻili: ʻO Resveratrol ʻo ia SAFE MAU PONO ke hoʻopili ʻia i ka ʻili a hiki i 30 mau lā.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO Resveratrol ʻo ia LIKELY SAFE ke hoʻohana ʻia i nā nui i loaʻa i kekahi mau meaʻai. Eia nō naʻe, i ka wā hāpai a me ka hānai ʻana i ka umauma, he mea nui ke kumu o resveratrol. Loaʻa ʻo Resveratrol i loko o nā ʻili hua waina, ka wai hua waina, ka waina, a me nā kumuwaiwai ʻē aʻe. ʻAʻole pono e hoʻohana ʻia ka waina ma ke ʻano he kumu o resveratrol i ka wā hāpai a me ka hānai ʻana i ka umauma.

Nā keiki: ʻO Resveratrol ʻo ia SAFE MAU PONO i nā keiki ke pīpī i nā pihi ihu a i 2 mau mahina.

Nā maʻi hōʻeha: Hoʻolohi paha ʻo Resveratrol i ke kāpili ʻana o ke koko a hoʻonui i ka makaʻu o ke kahe ʻana i ka poʻe me nā maʻi koko.

ʻO ke kūlana Hormone-sensitive e like me ka maʻi ʻaʻai umauma, maʻi ʻaʻai uterine, ovarian cancer, endometriosis, a i ʻole uterine fibroids: E hana paha ʻo Resveratrol e like me ka estrogen. Inā loaʻa iā ʻoe kekahi ʻano e ʻoi aku paha ka maikaʻi ma o ka hōʻike ʻana i ka estrogen, mai hoʻohana i ka resveratrol.

ʻOki kino: Hoʻonui ka Resveratrol i ka makaʻu o ke kahe i ka wā a ma hope o ke kaha ʻana. E hōʻoki i ka hoʻohana ʻana i resveratrol ma kahi o 2 mau pule ma mua o kahi ʻōpala i hoʻonohonoho ʻia.

Kānāwai

E akahele me kēia hui ʻana.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 1A1 (CYP1A1) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, ʻo ka lawe ʻana i resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ʻo chlorzoxazone, theophylline, a me bufuralol.

Ua hoʻololi ʻia nā lāʻau e ke ake (Cytochrome P450 1A2 (CYP1A2) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, lawe i ka resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia nō ʻo clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propranol ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), a me nā mea ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 1B1 (CYP1B1) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, lawe i ka resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ka theophylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib, a me caffeine.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C19 (CYP2C19) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, lawe i ka resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa ʻo ia hoʻi ʻo amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin, a me nā mea ʻē aʻe ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2E1 (CYP2E1) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, ʻo ka lawe ʻana i resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ka acetaminophen, chlorzoxazone (Parafon Forte), ethanol, theophylline, a me nā anesthetics e like me enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 3A4 (CYP3A4) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Resveratrol i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. I ke kumumanaʻo, lawe i ka resveratrol me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa e hoʻonui ai i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Eia nō naʻe, hōʻike kekahi o nā noiʻi mua i nā hopena hakakā.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia nō kekahi mau blockers channel calcium (diltiazem, nicardipine, verapamil), chemotherapeutic agents (etoposide, paclitaxel, vinblastine, vincristine, vindesine), antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanuls (Alfenta) ), fentanyl (Sublimaze), tutupocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Versed), a me nā mea ʻē aʻe.

Nā lāʻau i hoʻolohi i ke kō ʻana o ke koko (Anticoagulant / Antiplatelet drug)

Hiki i ka Resveratrol ke hoʻolohi i ke kō ʻana o ke koko. Lawe i ka resveratrol me nā lāʻau lapaʻau e hōʻemi ana hoʻi i ka ʻōpala ʻana e hoʻonui ai i ka manawa o ka palapū a me ke kahe ʻana o ke kahe.

ʻO kekahi mau lāʻau e lohi ai ke kāpili ʻana o ke koko me aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, a me nā mea ʻē aʻe), ibuprofen (Advil, Motrin, a me nā mea ʻē aʻe), naproxen (Anaprox, Naprosyn, a me nā mea ʻē aʻe), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), a me nā mea ʻē aʻe.

Nā mea kanu a me nā mea hoʻopili e lohi ai i ke kāpili ʻana o ke koko (Anticoagulant / Antiplatelet herbs and supplement)

Hiki i ka Resveratrol ke hoʻolohi i ke kō ʻana o ke koko. ʻO ka hoʻohana ʻana ia me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopili e hōʻohi paha i ke kāpili ʻana o ke koko i hiki ke hoʻonui i ka makaʻu o ke kahe ʻana a i ʻole ka palapū i kekahi poʻe. Hoʻopili kēia mau mea kanu me angelica, clove, danshen, feverfew, kālika, ginger, ginkgo, ginseng Panax, chestnut lio, clover ʻulaʻula, turmeric, a me nā mea ʻē aʻe.

Nā mea momona a me nā mea momona

Lawe i ka resveratrol me kahi ʻai e kiʻekiʻe ana i ka momona e hoʻoliʻiliʻi paha i ka nui o ka resveratrol i lawe ʻia e ke kino.

Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

NA MAKAHIKI

E ka waha:

• No nā kau ʻaina kau (hay fever): ʻElua mau sprays o kahi 0.1% resveratrol nasal spray i loko o kēlā me kēia nostril ʻekolu mau manawa / lā a hiki i 4 mau pule.
• No ka momona: 500 mg a ʻoi iki paha o resveratrol i kēlā me kēia lā no 3 mau mahina a ʻoi paha.

3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin, Protykin, ʻĀina Waina ʻulaʻula, Resvératrol, Resveratrols, Resvératrols, RSV, RSVL, Stilbene Phytoalexin, Trans-Resveratrol, Trans-Resvératrol, ʻĀina Waina, Pila Waina.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. ʻO Zhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. Chinese yam (Dioscorea contradita Thunb.) Hoʻoliʻiliʻi i ka maʻi diarrhea pili i nā antibiotic, hoʻololi i ka microbiota ʻōpū, a hoʻonui i ka pae o nā waikawa momona liʻiliʻi i nāʻiole. ʻOihana Res Int. 2019; 122: 191-198. Nānā kiʻi ʻole.
2. Akbari M, Tamtaji OR, Lankarani KB, et al. Nā hopena o ka resveratrol supplementation ma ka hana endothelial a me nā kaomi koko i waena o nā mea maʻi me ka metabolic syndrome a me nā maʻi e pili pū ana: kahi loiloi ʻōnaehana a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻole ʻia. ʻO ke koko kiʻekiʻe Cardiovasik Prev 2019; 26: 305-19. Nānā kiʻi ʻole.
3. Köbe T, Witte AV, Schnelle A, et al. Ka hopena o ka resveratrol ma ka mālama ʻana i ka glucose, ke ʻano o ka hippocampal a me ka hoʻopili ʻana, a me ka hana hoʻomanaʻo i nā mea maʻi me ka hoʻohaʻahaʻa noʻonoʻo ʻole. Front Neurosci 2017; 11: 105. Nānā kiʻi ʻole.
4. Witte AV, Kerti L, Margulies DS, Flöel A. Nā hopena o resveratrol i ka hana hoʻomanaʻo, ka hoʻopili ʻana o ka hana hippocampal, a me ka metabolism glucose i nā mākua olakino olakino. ʻO J Neurosci 2014; 34: 7862-70. Nānā kiʻi ʻole.
5. Mousavi SM, Milajerdi A, Sheikhi A, et al. Hoʻoikaika ka hoʻohui Resveratrol i nā ana momona: kahi loiloi ʻōnaehana a me ka hopena-pane meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻia. ʻO Obes Rev 2019; 20: 487-98. Nānā kiʻi ʻole.
6. ʻO Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol hoʻemi i ka albuminuria i ka nephropathy diabetic: kahi hoʻokolohua hoʻokolohua hoʻokolohua hoʻokolohua kaulua ʻia. ʻO Diabeta Metab 2019; 45: 53-9. Nānā kiʻi ʻole.
7. Zhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Ka pono o ka Resveratrol Hoʻohui kūʻē i nā Non-Alcoholic Fatty Liver Disease. PLoS Hoʻokahi. 2016 Aug 25; 11: e0161792. Nānā kiʻi ʻole.
8. Poulsen MK, Nellemann B, Bibby BM, et al. ʻAʻohe hopena o resveratrol ma nā kinetics VLDL-TG a me ka noʻonoʻo insulin i nā kāne momona me ka maʻi akepaʻa momona ʻole. ʻO Diabetes Obes Metab. 2018; 20: 2504-2509. Nānā kiʻi ʻole.
9. Hussain SA, Marouf BH, Ali ZS, Ahmmad RS. Ka maikaʻi a me ka palekana o ka hui pū ʻana o resveratrol me meloxicam i nā mea maʻi me ka osteoarthritis kuli: kahi noiʻi hoʻokele ma waena o ka pailaka. ʻO Clin Interv Aging. 2018; 13: 1621-1630. Nānā kiʻi ʻole.
10. Huhn S, Beyer F, Zhang R, et al. Nā hopena o ka resveratrol i ka hana hoʻomanaʻo, ka hoʻopili ʻana o ka hippocampus a me ka microstructure i nā mākua - He hoʻokolohua hoʻokolohua kaulike ʻole ʻia. Neuroimage. 2018; 174: 177-190. Nānā kiʻi ʻole.
11. Haghpanah S, Zarei T, Eshghi P, et al. Ka maikaʻi a me ka palekana o resveratrol, kahi hemoglobin waha he mea hoʻonui F, i nā mea maʻi me ka beta-thalassemia intermedia. Ann Hematol. 2018; 97: 1919-1924. Nānā kiʻi ʻole.
12. Anton SD, Ebner N, Dzierzewski JM, et al. Nā hopena o 90 Lā o ka Resveratrol Kākoʻo ma ka Cognitive Hana i nā Kūpuna: ʻO kahi Pilot Study. J Hoʻohui Hou Med. 2018; 24: 725-732. Nānā i nā abstract.
13. Lv C, Zhang Y, Shen L. Loiloi mua hopena hopena o resveratrol i nā mākua me ka rhinitis āpau. Int Arch Allergy Immunol 2018; 175: 231-6. Nānā kiʻi ʻole.
14. Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Hoʻohui Resveratrol i nā maʻi Schizophrenia: ʻO kahi hoʻokolohua hoʻokolohua kaulike e loiloi ana i ka Glucose Serum a me nā mea ʻino Cardiovascular. Nutrients. 2016; 8: 73. Nānā kiʻi ʻole.
15. ʻO Wightman EL, Haskell-Ramsay CF, Reay JL, et al. Nā hopena o ka supplement trans-resveratrol mau ma nā ʻano o ka hana o ka noʻonoʻo, ka naʻau, ka hiamoe, ke olakino a me ke kahe o ke kahe cerebral i ke olakino, ʻōpio kanaka. ʻO Br J Nutr. 2015; 114: 1427-37. Nānā kiʻi ʻole.
16. ʻO Turner RS, Thomas RG, Craft S, et al. ʻO kahi hoʻokolohua kaulua ʻole, makapō makapō, kahi hoʻokolokolo i ka resveratrol no ka maʻi Alzheimer. Neurology. 2015; 85: 1383-91. Nānā kiʻi ʻole.
17. Timmers S, de Ligt M, Phielix E, et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: He Randomized Controlled Trial. Mālama Diabetes. 2016; 39: 2211-2217. Nānā kiʻi ʻole.
18. ʻO Samsami-Kor M, ʻo Daryani NE, ʻo Asl PR, ʻo Hekmatdoost A. Nā hopena anti-Inflammatory o Resveratrol i nā maʻi me ka ulcerative colitis: kahi Randomized, Double-Blind, Placebo-control Pilot Study. ʻO Arch Med Res. 2015; 46: 280-5. Nānā kiʻi ʻole.
19. Lin CT, Lā XY, Lin AX. Hoʻonui ka hoʻopili me ka trans-resveratrol dosis kiʻekiʻe i ka ultrafiltration i loko o nā mea maʻi dialysis peritoneal: kahi noiʻi prospective, randomized, blind-blind. ʻO Ren Fail. 2016; 38: 214-21. Nānā kiʻi ʻole.
20. Kjaer TN, Ornstrup MJ, Poulsen MM, et al. Hoʻoemi ʻo Resveratrol i nā pae o ka holo mua o androgen precursors akā ʻaʻohe ona hopena ma, testosterone, dihydrotestosteron, pae PSA a i ʻole ka nui o ka prostate. ʻO ka hoʻāʻo ʻana o 4 mau mahina i nā kāne waena. Moekolohe. 2015; 75: 1255-63. Nānā kiʻi ʻole.
21. Evans HM, Howe PR, Wong RH. Nā hopena o Resveratrol i ka hana cognitive, Mood a me Cerebrovascular Hana i nā wahine Post-Menopausal; He 14-Week Randomized Placebo-Controll Intervent Trial. Nutrients. 2017; 9. Nānā kiʻi ʻole.
22. Elgebaly A, Radwan IA, AboElnas MM, et al. Hoʻohui Resveratrol i nā maʻi me ka maʻi ʻona ʻona ʻole Alkohola: Nānā ʻōnaehana a me ka Meta-analysis. ʻO J Gastrointestin Liver Dis. 2017; 26: 59-67.Nānā kiʻi ʻole.
23. Bo S, Ponzo V, Ciccone G, et al. ʻEono mau mahina o ka resveratrol supplementation ʻaʻohe hopena i ana ʻia i nā maʻi diabetic ʻano 2. Hoʻohuli makapō, makapō makapō, hoʻokolokolo-kaohi hoʻokolokolo ʻO Pharmacol Res. 2016; 111: 896-905. Nānā kiʻi ʻole.
24. ʻO Bedada SK, Neerati P. Resveratrol Pretreatment e hoʻopili iā CYP2E1 Hana o Chlorzoxazone i nā mea manawaleʻa olakino olakino. ʻO Phytother Res. 2016; 30: 463-8. Nānā kiʻi ʻole.
25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Nā hopena o Resveratrol ma Polycystic Ovary Syndrome: He makapō makapō, Hoʻohālikelike ʻia, kahi hoʻokolokolo me ka Placebo. ʻO J Clin Endocrinol Metab. 2016; 101: 4322-4328. Nānā kiʻi ʻole.
26. Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol ma ke ʻano he adjuvant therapy maikaʻi i ka mālama ʻana i ka rheumatoid arthritis: kahi noiʻi hoʻokolohua. ʻO Clin Rheumatol. 2018; [Epub ma mua o ka paʻi]. Nānā kiʻi ʻole.
27. Shishodia S, Aggarwal BB. Resveratrol: kahi polyphenol no nā kau āpau. Resveratrol i ke olakino a me nā maʻi. ʻO Boca Raton, FL: CRC Press, 2005.
28. Creasy LL, Kope M. Phytoalexin i hiki ke hana i nā hua waina. ʻO J Am Soc Hortic Sci. 1988; 113: 230-234.
29. Langcake P, McCarthy W. ʻO ka pilina o ka hana resveratrol i ka maʻi o nā lau waina e Botrytis cinerea. Vitis. 1979; 18: 244-253.
30. ʻO NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. Koi ʻia ʻo SIRT1 no ka hoʻoulu ʻana o AMPK a me nā hopena maikaʻi o resveratrol ma ka hana mitochondrial. Pūnaewele Metab. 2012 Mei 2; 15: 675-90. Nānā kiʻi ʻole.
31. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Nā ʻike hou o ka polyphenols papaʻai a me ka momona. ʻO J Nutr Biochem. 2014 Ian; 25: 1-18. Nānā kiʻi ʻole.
32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Kaohi ʻana o ka maʻi influenza A virus e resveratrol. ʻO J Infect Dis. 2005 Mei 15; 191: 1719-29. Nānā kiʻi ʻole.
33. Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, Restignoli R, Francioso A, Mosca L. Resveratrol e kāohi i ke kope ʻana o rhinovirus a me ka hōʻike o nā mea hoʻolauna uila i ka epithelia nasal. ʻO Antiviral Res. 2015 Nov; 123: 15-21. Nānā kiʻi ʻole.
34. ʻO Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Pākuʻi pū kekahi i hoʻopili ʻia me Resveratrol. Toxicol Sci. 2004 Dec; 82: 614-9. Nānā kiʻi ʻole.
35. Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Resveratrol pae a me nā kumu make āpau i nā mākua e noho ana i ke kaiāulu. ʻO JAMA Intern Med. 2014 Jul; 174: 1077-84. Nānā kiʻi ʻole.
36. Sahebkar A. Nā hopena o ka resveratrol supplementation ma plasma lipids: kahi ʻōnaehana loiloi a me meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻia. Nutr Rev. 2013 Dec; 71: 822-35. Nānā kiʻi ʻole.
37. ʻO Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G. Resveratrol a me carboxymethyl-ß-glucan e hoʻoliʻiliʻi i nā hōʻailona nasal i nā keiki me ka rhinitis aleren i hoʻopili ʻia e ka pollen. ʻO Curr Med Res Opin. 2014 ʻOkakopa; 30: 1931-5. Nānā kiʻi ʻole.
38. ʻO Méndez-del Villar M, ʻo González-Ortiz M, ʻo Martínez-Abundis E, ʻo Pérez-Rubio KG, ʻo Lizárraga-Valdez R. Ka hopena o ka hoʻoponopono resveratrol ma ka metabolic syndrome, ka ʻike insulin, a me ka huna o ka insulin. Kūpono ʻole ʻo Metab Syndr Relat Disord. 2014 Dec; 12: 497-501. Nānā kiʻi ʻole.
39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection e resveratrol: ʻO kahi hoʻokolohua hoʻokolohua kanaka i nā mea maʻi me ka maʻi paʻa o ka coronary artery. ʻO Clin Hemorheol Microcirc. 2012; 50: 179-87. Nānā kiʻi ʻole.
40. Liu K, Zhou R, Wang B, Mi MT. Ka hopena o ka resveratrol ma ka mālama ʻana i ka glucose a me ka noʻonoʻo ʻana o ka insulin: kahi meta-analysis o 11 mau hoʻokolohua hoʻokolohua paʻa ʻia. ʻO Am J Clin Nutr. 2014 Iune; 99: 1510-9. Nānā kiʻi ʻole.
41. ʻO Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation e hoʻomaikaʻi i nā biomarkers inflammatory i nā mea maʻi me ka maʻi akepaʻa momona ʻole. ʻO Nutr Res. 2014 ʻOkakopa; 34: 837-43. Nānā kiʻi ʻole.
42. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. ʻAʻole pōmaikaʻi ʻo Resveratrol i nā mea maʻi me ka maʻi akepaʻa momona ʻole. ʻO Gastroenterol Hepatol. 2014 Dec; 12: 2092-103.e1-6. Nānā kiʻi ʻole.
43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., a me Willoughby, DS Resveratrol Kākoʻo a me nā Loli i Glucose, Insulin, A me ka mRNA Expression e pili ana i ka hoʻoikaika kino i nā wahine nui keu: 2467. Lapaʻau & ʻEpekema i nā Pāʻaina & hoʻoikaika kino 2011; 43
44. ʻO Guarnieri, R., Pappacoda, A., a me Solitro, S. [A resveratrol i loko o ka mea hoʻohui e hoʻoliʻiliʻi i ke kaumaha oxidative a hoʻonui i nā ʻōuli maʻi maʻi i nā mea COPD] . ʻO Cochrane Central Register o nā hoʻokolohua i kāohi ʻia 2009;
45. Yoon, SJ, Cho, KS, Lee, YH, Kim, DS, a me Hong, SJ RESVERATROL INHIBITS CXCR4 MEDIATED TUMOR GROWTH AND MIGRATION OF HUMAN KIDNEY CANCER CELL IN VITRO AND IN VIVO: 428. Journal of Urology 2009; 181: 153- 154.
46. Klink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV, a me Freedland, S. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH: 724. Pai. o Urology 2009; 181
47. Seely, K. A. Cannabinoid receptor inverse agonists ma ke ʻano he novel therapeutic agents. "The Science and Engineering. The Science and Engineering 2009; 70 (4-B)
48. ʻO Pregliasco, F. a me Cogo, R. [Antioxidant a me nā mea hoʻopili i ka poʻe ʻelemakule e hana ana i ka wīwī influenza o ke kau e hoʻomaikaʻi i ka pane serological a hoʻemi i nā hanu hanu] Lʻuso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana no laila. ʻO Cochrane Central Register o nā hoʻokolohua i kāohi ʻia 2010;
49. Steigerwald, M. D., Fisk, M. Z., Smoliga, J. M., a me Rundell, K. W. Nā hopena o ka Resveratrol ma ke kaomi oxidative a me ka hana vascular ma hope o ka hoʻoikaika kino i ka poli air simulated: 2645. Lapaʻau & ʻEpekema i nā Sports & Exercise 2011; 43
50. ʻO kert, J., Smoliga, JM, kert, KM, a me Maroon, JC ʻEkolu mau mahina ʻ Orlelo waha o kahi hui Polyphenol Unique e hoʻomaikaʻi i nā hōʻike hōʻike kino a me nā neurocognitive i nā mākua sedentary: 2205. Lapaʻau & ʻEpekema i nā Sports & Exercise 2008; 40: S246 .
51. Grujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., a me Jovovic, DJ RESVERATROL HOOPAU I KE KUMU KANAKA, NUI O ANTIOXIDANT NĀ HANA ENZYME A ME NĀ PALAPALA HISTOLOGICAL IN MODEL EXPERIMENTAL O MALIGNANT HYPERTENSION PP.29.171. Ka Nūpepa o Hypertension 2010; 28
52. Pendurthi, U. R., Williams, J. T., a me Rao, L. V. Resveratrol, kahi hui polyphenolic i loaʻa i loko o ka waina, kāohi i ke ʻano o nā mea i loko o nā hunaola vaskular. Arterioscler. Thomb. Vasc.Biol 1999; 19: 419-426. Nānā kiʻi ʻole.
53. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., a me Cerletti, C. Ka hopena o trans-resveratrol, kahi polyphenolic maoli hoʻohuihui, ma ka hana leukocyte polymorphonuclear kanaka. ʻO Br.J.Farmacol. 1998; 123: 1691-1699. Nānā kiʻi ʻole.
54. ʻO Bhatt, J. K., Thomas, S., a me Nanjan, M. J. Resveratrol supplementation e hoʻomaikaʻi i ka kaohi glycemic i ka type 2 diabetes mellitus. Nā Nutr.Res. 2012; 32: 537-541. Nānā kiʻi ʻole.
55. ʻO Hector, K. L., Lagisz, M., a me Nakagawa, S. Ka hopena o resveratrol i ka lōʻihi o ke ola ma waena o nā laha: kahi meta-analysis. Biol.Lett. 10-23-2012; 8: 790-793. Nānā kiʻi ʻole.
56. ʻO Roehr, B. Ua hana ka mea noiʻi Cardiovascular i ka ʻikepili i ka noiʻi ʻana i ka waina ʻulaʻula. BMJ 2012; 344: e406. Nānā kiʻi ʻole.
57. ʻO Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., a me Barzilai, N. Ke aʻo Pilot o resveratrol i nā mākua makua me ka hoʻomanawanui ʻole o ka glucose. J.Gerontol.A Biol.Sci.Med.Sci. 2012; 67: 1307-1312. Nānā kiʻi ʻole.
58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., a me Das, DK Hoʻololi resveratrol Longevinex hoʻonui i ka endothelial function. i nā mākua me ka maʻi metabolic e loaʻa ana i ka lāʻau maʻamau. Nutr.Res 2011; 31: 842-847. Nānā kiʻi ʻole.
59. Timmers, S., Konings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., a me Schrauwen, P. Nā hopena like me ka pāʻina pālolo o 30 mau lā o ka resveratrol supplementation on ikehu metabolism a me ka metabolic pili ma obese kanaka. Pūnaewele Metab 11-2-2011; 14: 612-622. Nānā kiʻi ʻole.
60. ʻO Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., a me Xu, D. Resveratrol e hoʻololi i ka murine collagen-induced arthritis e ka pāpā ʻana iā Th17 a me B-cell function. Ann. Reum. Hōʻike 2012; 71: 129-135. Nānā kiʻi ʻole.
61. Naita, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., a me Rossetti, L. Mediobasal hypothalamic SIRT1 pono no resveratrol's effects ma ka hana insulina i nāʻiole. Diabetes 2011; 60: 2691-2700. Nānā kiʻi ʻole.
62. Howells, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, a me Gescher, AJ Phase I randomized, pālua makapō hoʻopaʻa haʻawina o micronized resveratrol (SRT501) i nā mea maʻi me nā metastases hepatic - palekana, pharmokinetics, a me nā pharmacodynamics. Ka maʻi 'aʻai Prev. Rees (Phila) 2011; 4: 1419-1425. Nānā kiʻi ʻole.
63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., a me Boos, N. Hōʻike ka resveratrol ʻulaʻula ʻulaʻula i ka hiki ke loaʻa ka hoʻomaʻamaʻa ʻana i ka ʻeha nukleus pulposus-mediated pain in vitro and in vivo. Spine (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Nānā kiʻi ʻole.
64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, LG, Sumegi, B., a me Wittmann, I. Resveratrol hoʻomaikaʻi i ka ʻike insulin, hoʻemi i ke koʻikoʻi oxidative a hoʻoulu i ke ala Akt i nā maʻi diabetic ʻano 2. ʻO Br J Nutr. 2011; 106: 383-389. Nānā kiʻi ʻole.
65. Fabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, a me Ayala, F. Resveratrol-i loaʻa ka gel no ka mālama ʻana i ka huehue vulgaris: kahi makapō hoʻokahi, kaohi kaʻa, ka hoʻokolohua pailaka. ʻO Am J Clin. Dermatol 4-1-2011; 12: 133-141. Nānā kiʻi ʻole.
66. ʻO Kitada, M., Kume, S., Imaizumi, N., a me Koya, D. Resveratrol hoʻomaikaʻi i ke koʻikoʻi oxidative a pale aku i ka nephropathy diabetic ma o ka normalization o ka maʻi Mn-SOD i ke ala kūʻokoʻa AMPK / SIRT1. Diabetes 2011; 60: 634-643. Nānā kiʻi ʻole.
67. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., a me Rostami, A. ʻO oral resveratrol ka mea e hōʻemi i ka hōʻino neuronal i kahi hiʻohiʻona o sclerosis maha. J Neuroophthalmol. 2010; 30: 328-339. Nānā kiʻi ʻole.
68. Brown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G., Brown, K., ʻO Steward, WP, Gescher, AJ, a me Brenner, DE Ka hana hou ʻana o ka lāʻau chemopreventive agents resveratrol i nā mea manawaleʻa olakino: palekana, pharmokinetics, a me ka hopena o ka axis factor grow-like grow. Pākuʻi Res 11-15-2010; 70: 9003-9011. Nānā kiʻi ʻole.
69. Patel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, West, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Steward, WP, ʻO Gescher, AJ, a me Brown, K. ʻO ka lāʻau lapaʻau lāʻau o resveratrol a me nā metabolites i nā mea maʻi maʻi maʻi kala. Pākuʻi Res 10-1-2010; 70: 7392-7399. Nānā kiʻi ʻole.
70. ʻO Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., a me Koch, A. Resveratrol e hoʻopilikia i ka hoʻokuʻu ʻia ʻana o nā cytokine inflammatory-resistable steroid. mai ke alaloa o ke kanaka air maʻa mau i nā hunaola i nā maʻi pulmonary mau loa. J Pharmacol. Exp. Tor 2010; 335: 788-798. Nānā kiʻi ʻole.
71. Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, a me Alberts, DS Hoʻololi ʻo DS Resveratrol i nā ʻenemona lāʻau-a me nā carcinogen-metabolizing i nā mea kōkua manawaleʻa hoʻopaʻa haʻawina. Ka maʻi 'aʻai maʻi. Res (Phila) 2010; 3: 1168-1175. Nānā kiʻi ʻole.
72. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., a me Berry, N. M. Hoʻonui ka resveratrol supplement i ka dilatation i waena o nā kānaka kaupaona / paona kiʻekiʻe me ke kiʻekiʻe o ke kahe o ke koko. Nutr.Metab Cardiovasc.Dis 2011; 21: 851-856. Nānā kiʻi ʻole.
73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., a me Cameron, DW Steady-State pharmacokinetics a me ka hoʻomanawanui o trans-resveratrol 2000 mg ʻelua mau lā me ka meaʻai, quercetin a me ka waiʻona (ethanol) i nā kumuhana ola kanaka. ʻO Clin.Farmacokinet. 2010; 49: 449-454. Nānā kiʻi ʻole.
74. Le Couteur, D. G. a me Sinclair, D. A. He blueprint no ka hoʻomohala ʻana i nā lāʻau lapaʻau e hoʻonui ai i ke olakino a hoʻopaneʻe i ka make. ʻO J Gerontol. ʻO Biol.Sci. ʻOed Sci. 2010; 65: 693-694. Nānā kiʻi ʻole.
75. Kennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., a me Haskell, CF Nā hopena o resveratrol ma nā kahe o ke kahe o ke kahe cerebral a me ka hana noʻonoʻo i nā kānaka: he makapō makapō, kahi placebo -e kāohi ʻia, ka hoʻokolokolo hoʻokolokolo. ʻO Am J Clin.Nutr. 2010; 91: 1590-1597. Nānā kiʻi ʻole.
76. Daffner, K. R. Ka paipai ʻana i ke kūnewa ʻana o ka naʻau ʻike: kahi loiloi piha. J Alzheimers. Hōʻike 2010; 19: 1101-1122. Nānā kiʻi ʻole.
77. ʻO Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C. H., a me Lau, Y. T. Resveratrol pale i ka hana endothelial a me ka hana superoxide aortic ma hope o ke kahe ʻana o ka trauma ma o ke ala hemeoxygenase-1 hilinaʻi i ka receptor. Crit Care Med 2010; 38: 1147-1154. Nānā kiʻi ʻole.
78. Albani, D., Polito, L., a me Forloni, G. Sirtuins ma ke ʻano he pahuhopu puke no ka maʻi ʻo Alzheimer a me nā maʻi neurodegenerative ʻē aʻe: hōʻike hoʻokolohua a me nā genetics. J Alzheimers. Hōʻike 2010; 19: 11-26. Nānā kiʻi ʻole.
79. ʻO Guo, J. P., Yu, S., a me McGeer, P. L. Simple in vitro assays e ʻike i nā blockers hōʻuluʻulu amyloid-beta no ka maʻi maʻi o Alzheimer. ʻO J Alzheimers. 2010; 19: 1359-1370. Nānā kiʻi ʻole.
80. ʻO Jha, R. K., Ma, Q., Sha, H., a me Palikhe, M. Ka hopena pale o resveratrol i ka ʻeha nui o ka lolo i hoʻokomo ʻia i ka pancreatitis. ʻO Pancreas 2009; 38: 947-953. Nānā kiʻi ʻole.
81. Zhang, H., Zhang, J., Ungvari, Z., a me Zhang, C. Resveratrol e hoʻomaikaʻi i ka hana endothelial: ke kuleana o TNF {alpha} a me ka stress vidative stress. Arterioscler.Thromb.Vasc.Biol. 2009; 29: 1164-1171. Nānā kiʻi ʻole.
82. ʻO Bournival, J., Quessy, P., a me Martinoli, M. G. Nā hopena pale o resveratrol a me quercetin e kūʻē i ka MPP + i hoʻoiho ʻia i ka hana oxidative e ka modulate markers o ka make apoptotic i nā neurons dopaminergic. Pūnaewele Mol.Neurobiol. 2009; 29: 1169-1180. Nānā kiʻi ʻole.
83. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lope, C., Rocha, JF, Nunes, T., Wright , L., a me Soares-da-Silva, P. Pharmacokinetic a me ka ʻike palekana o trans-resveratrol i ka piʻi ʻana o nā haʻawina he nui i nā manawaleʻa olakino. Mol.Nutr.Food Res 2009; 53 Hōʻuluʻulu 1: S7-15. Nānā kiʻi ʻole.
84. Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., a me Marambaud, P. Therapeutic Loaʻa paha o resveratrol i ka maʻi o Alzheimer. BMC.Neurosci. 2008; 9 Hōʻawi 2: S6. Nānā kiʻi ʻole.
85. Fan, E., Zhang, L., Jiang, S., a me Bai, Y. Nā hopena maikaʻi o resveratrol ma atherosclerosis. J Med Meaʻai 2008; 11: 610-614. Nānā kiʻi ʻole.
86. Vaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lope, C., Soares, E., Wright, L., Almeida, L., a me ʻO Soares-da-Silva, P. Ka hopena o ka meaʻai ma ka profile farmakokinetic o trans-resveratrol. Int.J Clin.Pharmacol.Ther 2008; 46: 564-570. Nānā kiʻi ʻole.
87. Dudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., a me Das, D. K. Kūpono paha ka waina keʻokeʻo no ka paradox Farani? Hoʻohālikelike i nā hopena cardioprotective o nā waina ʻulaʻula a me keʻokeʻo a me nā mea i koho ʻia: resveratrol, tyrosol, a me hydroxytyrosol. J Agric. ʻO Kemika ʻAi. 10-22-2008; 56: 9362-9373. Nānā kiʻi ʻole.
88. Orallo, F. Trans-resveratrol: he elixir kupua o ka ʻōpio mau loa? ʻO Curr. ʻO Med Chem. 2008; 15: 1887-1898. Nānā kiʻi ʻole.
89. Rocha-Gonzalez, H. I., Ambriz-Tututi, M., a me Granados-Soto, V. Resveratrol: kahi hui kūlohelohe me ka hiki i ka lāʻau i nā maʻi neurodegenerative. CNS. Neurosci .her 2008; 14: 234-247. Nānā kiʻi ʻole.
90. Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, a ʻO Rizzarelli, E. Ka pane ʻana o ke koʻikoʻi cellular: kahi pahuhopu puke no ka chemoprevention a me ka neuroprotection kino i ka ʻelemakule, nā maʻi neurodegenerative a me ka lōʻihi. Neurochem .Res 2008; 33: 2444-2471. Nānā kiʻi ʻole.
91. ʻO Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Kumukūʻai, NL, Labinskyy, N., Swindell, WR, Kamara, D., Minor, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P., Ingram, DK, Wolf, NS, Ungvari, Z., Sinclair, DA, a me de Cabo, ua hoʻopaneʻe ʻo R. Resveratrol i ka hōʻino ʻia e pili ana i nā makahiki a me nā mimics transcriptional i nā ʻaoʻao o ke kaohi papaʻai me ka ʻole o ka lōʻihi o ke ola. Pūnaewele Metab. 2008; 8: 157-168. Nānā kiʻi ʻole.
92. Dong, W., Li, N., Gao, D., Zhen, H., Zhang, X., a me Li, F. Resveratrol hoʻonāukiuki i ka lolo o ka lolo ischemic i ka manawa lohi ma hope o ka hahau ʻana a hoʻoulu i ka ʻelele RNA a me protein i hōʻike ʻia no angiogenic kumumea. J Vasc.Surg. 2008; 48: 709-714. Nānā kiʻi ʻole.
93. ʻO Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C. H., a me Lau, Y. T. Resveratrol hoʻonāukiuki i ka hōʻeha hepatic ma hope o ka trauma-hemorrhage ma o ke ala e pili ana i ka receptor estrogen. Nānā 2008; 30: 324-328. Nānā kiʻi ʻole.
94. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., a me Partridge, L. Nā hopena o resveratrol i ke ola i Drosophila melanogaster a me Caenorhabditis elegans. Mech. ʻAgeing Dev 2007; 128: 546-552. Nānā kiʻi ʻole.
95. Gruber, J., Tang, S. Y., a me Halliwell, B.ʻO nā hōʻike no ke kālepa ma waena o ke ola a me ke olakino i hoʻokumu ʻia e resveratrol lapaʻau o Caenorhabditis elegans. Ann N Y.Acad Sci 2007; 1100: 530-542. Nānā kiʻi ʻole.
96. ʻO Baur, J. A. a me Sinclair, D. A. Therapeutic Loaʻa o resveratrol: ka hōʻike vivo. Nat Rev Lāʻau Discov. 2006; 5: 493-506. Nānā kiʻi ʻole.
97. ʻO Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., a me Cellerino, ʻo A. Resveratrol hoʻolōʻihi i ka lōʻihi o ke ola a hoʻoliʻiliʻi i ka hoʻomaka ʻana o nā māka e pili ana i nā makahiki i ka vertebrate pōkole. Curr Biol 2-7-2006; 16: 296-300. Nānā kiʻi ʻole.
98. Rakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., a me Akar, F. Nā hopena o resveratrol i ka leo vascular a me ka hana endothelial o ke aʻa koko a me nā aʻa o ka mammary o loko. Int.J Cardiol 11-2-2005; 105: 209-215. Nānā kiʻi ʻole.
99. Ma, Z. H. a me Ma, Q. Y. Resveratrol: kahi lāʻau lapaʻau no ka pancreatitis koʻikoʻi. Honua J Gastroenterol. 6-7-2005; 11: 3171-3174. Nānā kiʻi ʻole.
100. ʻO Molnar, V. a me Garai, J. ʻO nā mea kanu i loaʻa i nā anti-inflammatory i hoʻopili ʻia i ka hana MIF tautomerase. Int.Immunopharmacol. 2005; 5: 849-856. Nānā kiʻi ʻole.
101. Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., a me Smorlesi, A. Ka hopena o resveratrol i ka hoʻomohala ʻana i nā tummary mammary spontan i HER-2 / nāʻiole transgenic. Int.J Kanesa 5-20-2005; 115: 36-45. Nānā kiʻi ʻole.
102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., a me Takada, Y. Ke kuleana o resveratrol i ka pale a me ka hoʻomaʻamaʻa ʻana o ka maʻi ʻaʻai. ʻO Anticancer Res. 2004; 24 (5A): 2783-2840. Nānā kiʻi ʻole.
103. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., a me Walle, U. K. Hoʻohui kiʻekiʻe akā haʻahaʻa haʻahaʻa i ka bioavailability o resveratrol waha i nā kānaka. ʻO ka hoʻolei ʻana o ka Metab Lapaʻau. 2004; 32: 1377-1382. Nānā kiʻi ʻole.
104. Jannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., a me Latruffe, N. Ka lawe ʻana o resveratrol, kahi luna chemopreventive cancer, i nā pahuhopu cellular: ka paʻa ʻana o ka protein plasmatic a me ka lawe ʻana o ka cell. ʻO Biochem.Pharmacol. 9-15-2004; 68: 1113-1118. Nānā kiʻi ʻole.
105. ʻO Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., a me Huang, E. S. 3,4 ', 5-Trihydroxy-trans-stilbene (resveratrol) ke kāohi nei i ka hana hou ʻana o ka cytomegalovirus kanaka a me nā hōʻailona cellular i hoʻokomo ʻia e nā virus. ʻO Antiviral Res. 2004; 63: 85-95. Nānā kiʻi ʻole.
106. ʻO Piver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., a me Lucas, D. Ka hoʻokomo ʻana i ka cytochrome P450 1A2 i ka biotransformation o trans-resveratrol i loko o nā microsome ate kanaka. . ʻO Biochem.Pharmacol. 8-15-2004; 68: 773-782. Nānā kiʻi ʻole.
107. ʻO Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., a me Sinclair, D. Sirtuin nā mea hoʻoulu e hoʻohālikelike i ka palena o ka calory a hoʻopaneʻe i ka ʻelemakule i nā metazoans. Nā Kūʻai 8-5-2004; 430: 686-689. Nānā kiʻi ʻole.
108. Olas, B., Wachowicz, B., Bald, E., a me Glowacki, R. Nā hopena pale o resveratrol e kūʻē i nā loli o ka platelet thiols i hoʻopili ʻia e nā hui platinum. ʻO J.Physiol Pharmacol. 2004; 55: 467-476. Nānā kiʻi ʻole.
109. Cavallaro, A., Ainis, T., Bottari, C., a me Fimiani, V. Ka hopena o resveratrol i kekahi mau hana o ke kaʻawale a me ke koko holoʻokoʻa neutrophil. ʻO Physiol Res. 2003; 52: 555-562. Nānā kiʻi ʻole.
110. Kim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, a me Choi, YH Hoʻohui o p21WAF1 / CIP1, pRB, Bax a me NF-kappaB i ka hoʻokomo ʻana i ka hopu a me ka apoptosis ulu e ka resveratrol i ka maʻi kanesa o ke kanaka. Nā pūnaewele A549. Int.J. ʻOncol. 2003; 23: 1143-1149. Nānā kiʻi ʻole.
111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., a me Sinclair , DA Hoʻohālikelike i nā mole mole liʻiliʻi o ka sirtuins e hoʻonui i ke ola Sacakaromyces cerevisiae. Nā Kūlana 9-11-2003; 425: 191-196. Nānā kiʻi ʻole.
112. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe , N., a me Solary, ʻo E. Resveratrol-i hoʻokomo ʻia apoptosis e pili me Fas redistribution i loko o nā kaupana a me ka hoʻokumu ʻana i kahi hōʻailona hōʻailona make-make i nā kolamu maʻi ʻaʻai kolona. J.Biol.Chem. 10-17-2003; 278: 41482-41490. Nānā kiʻi ʻole.
113. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., a me Lin, J. K. Resveratrol-i hoʻokomo ʻia ʻo G2 ma o ka pāpā ʻana o CDK7 a me p34CDC2 kinase i nā kolone maʻi kanaloko HT29. ʻO Biochem.Pharmacol. 4-1-2003; 65: 1053-1060. Nānā kiʻi ʻole.
114. Klinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., a me Jungbauer, A. ʻOihana Estrogenic i nā keʻokeʻo keʻokeʻo a me nā ʻulaʻula. ʻO J Agric. Meaʻai Meaʻai 3-26-2003; 51: 1850-1857. Nānā kiʻi ʻole.
115. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., a me Merillon, JM Hoʻolaha o [14C] -trans-resveratrol, a polyphenol chemopreventive cancer, ma nā iole iole ma hope o ka hoʻoponopono waha. Life Sci 4-4-2003; 72: 2219-2233. Nānā kiʻi ʻole.
116. Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, a me Ioredane, hana ʻo VC Resveratrol ma ke ʻano he estrogen receptor (ER) agonist i loko o nā umauma maʻi ʻaʻai umauma paʻa. hoʻololi ʻia me ER alpha. Int. J. Kanela 5-1-2003; 104: 587-596. Nānā kiʻi ʻole.
117. Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., a me van Breemen, R. B. Liquid chromatography / tandem mass spectrometric hoʻoholo o ka pāpā ʻana i nā isozymes kanaka cytochrome P450 e resveratrol a me resveratrol-3-sulfate. ʻO Rapid Commun.Mass Spectrom. 2003; 17: 307-313. Nānā kiʻi ʻole.
118. ʻO Olas, B., Wachowicz, B., Saluk-Juszczak, J., a me Zielinski, T. Ka hopena o resveratrol, kahi hui polyphenolic kūlohelohe, ma ka hoʻoiho platelet i hoʻokomo ʻia e endotoxin a thrombin paha. Thromb. Res 8-15-2002; 107 (3-4): 141-145. Nānā kiʻi ʻole.
119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., a me Forstermann, U. Resveratrol, kahi poltohenolic phytoalexin i loaʻa i ka waina ʻulaʻula, hoʻonui i ka hōʻike a me ka hana o endothelial nitric oxide synthase. Kaapuni 9-24-2002; 106: 1652-1658. Nānā kiʻi ʻole.
120. ʻO Sharma, M. a me Gupta, Y. K. ʻO ka hana maʻamau me trans resveratrol kaohi i ka intracerebroventricular streptozotocin i hoʻokomo ʻia i ka hōʻino o ka noʻonoʻo a me ke koʻikoʻi oxidative i nāʻiole. Life Sci 10-11-2002; 71: 2489-2498. Nānā kiʻi ʻole.
121. ʻO Holian, O., Wahid, S., Atten, M. J., a me Attar, B. M. Ka pāpā ʻana i ka hoʻonui ʻia ʻana o ka cell cancer cancer e resveratrol: ka hana a ka nitric oxide. Am.J. Phhysiol Gastrointest. Lāhui Physiol 2002; 282: G809-G816. Nānā kiʻi ʻole.
122. Potter, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, Lamb, JH, Farmer, PB, Stanley, LA, and Burke, MD ʻO ka mea pale pale maʻi maʻi ua hoʻohuli ʻia ʻo resveratrol i ka agice anticancer piceatannol e ka cytochrome P450 enzyme CYP1B1. Br.J. Kakela 3-4-2002; 86: 774-778. Nānā kiʻi ʻole.
123. Falchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., a me Ravagnan, G. Nā hopena o resveratrol i ka hana o ke kanaka immune immune. ʻO Life Sci. 11-21-2001; 70: 81-96. Nānā kiʻi ʻole.
124. Bhavnani, BR, Cecutti, A., Gerulath, A., Woolever, AC, a me Berco, M. Hoʻohālikelike i nā hopena antioxidant o nā equine estrogens, nā ʻāpana waina ʻulaʻula, nā huaora E, a me nā probucol ma ka hoʻohaʻahaʻa lipoprotein haʻahaʻa haʻahaʻa i nā wahine postmenopausal . Menopause. 2001; 8: 408-419. Nānā kiʻi ʻole.
125. ʻO Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., a me Pezzuto, J. M. Estrogenic a me nā antiestrogenic waiwai o resveratrol i nā mammary tumor models. ʻO Res. 10-15-2001; 61: 7456-7463. Nānā kiʻi ʻole.
126. Lee, J. E. a me Safe, S. Ka hoʻokomo ʻana i kahi hana post-transcriptional i ka pāpā o ka CYP1A1 expression e resveratrol i nā pūnaʻi maʻi ʻaʻai umauma. ʻO Biochem.Pharmacol. 10-15-2001; 62: 1113-1124. Nānā kiʻi ʻole.
127. ʻO Bhat, K. P. a me Pezzuto, ʻo J. M. Resveratrol hōʻike i nā waiwai cytostatic a me antiestrogenic me nā cell endenia adenocarcinoma (Ishikawa). ʻO Res. 8-15-2001; 61: 6137-6144. Nānā kiʻi ʻole.
128. ʻO Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., a me Tredici, G. Anati-apoptotic hopena o trans-resveratrol ma paclitaxel-i hoʻokomo ʻia apoptosis i loko o ke kanaka neuroblastoma SH-SY5Y pūnaewele pūnaewele. Neurosci.Lett. 4-13-2001; 302: 41-44. Nānā kiʻi ʻole.
129. ʻO Giovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filopio, C., a me Bertelli, A. Resveratrol, kahi polyphenol i loaʻa i ka waina, hoʻemi i ka ʻeha ischemia reperfusion i hakuʻala ʻiole. ʻO J Cardiovasc.Parmarmol. 2001; 37: 262-270. Nānā kiʻi ʻole.
130. ʻO Chan, W. K. a me Delucchi, A. B. Resveratrol, kahi mea inu waina ʻulaʻula, kahi inactivator i hoʻokumu ʻia o cytochrome P450 3A4. Life Sci 11-10-2000; 67: 3103-3112. Nānā kiʻi ʻole.
131. Wang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., a me Kuo, J. S. Resveratrol keakea i ka interleukin-6 i hana ʻia i loko o nā cell glial mixed glial ma lalo o ka hypoxia / hypoglycemia ukali ʻia e reoxygenation. J Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Nānā kiʻi ʻole.
132. Chang, T. K., Lee, W. B., a me Ko, H. H. Trans-resveratrol hoʻololi i ka hana catalytic a me ka mRNA hōʻike o ka procarcinogen-activating kanaka cytochrome P450 1B1. Can.J.Physiol Pharmacol. 2000; 78: 874-881. Nānā kiʻi ʻole.
133. Burkitt, M. J. a me Duncan, J. Nā hopena o trans-resveratrol ma ka hoʻokumu ʻia ʻana o ka hydroxyl-radical a me ka hōʻino ʻia ʻana o DNA: nā hōʻike no ka scavenging hydroxyl-radical a me kahi puke, a me ka mīkini glutathione. Arch.Biochem.Biophys. 9-15-2000; 381: 253-263. Nānā kiʻi ʻole.
134. Zbikowska, H. M. a me Olas, B. Nā Antioxidant me ka hana carcinostatic (resveratrol, wikamina E a me ka selenium) i ka modulate o ka hoʻopili platelet. ʻO J Physiol Pharmacol. 2000; 51: 513-520. Nānā kiʻi ʻole.
135. ʻO Kirk, R. I., Deitch, J. A., Wu, J. M., a me Lerea, K. M. Resveratrol e hoʻēmi i nā hanana hōʻailona mua i nā platelet i holoi ʻia akā ʻaʻole hopena iki i ka platalet i nā meaʻai āpau. Nā Kino Koko Mol. 2000; 26: 144-150. Nānā kiʻi ʻole.
136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., a me Pruess, H. G. Nā radical manuahi a me nā hua hua waina proanthocyanidin i unuhi ʻia: koʻikoʻi i ke olakino kanaka a me ka pale ʻana i nā maʻi. Toxicology 8-7-2000; 148 (2-3): 187-197. Nānā kiʻi ʻole.
137. Bradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., a me De Jong, J. W. Hoʻopili paha ka resveratrol i nā preconditioning pharmacological? Ua hana ʻo Int.J Tissue React. 2000; 22: 1-4. Nānā kiʻi ʻole.
138. Naderali, E. K., Doyle, P. J., a me Williams, G. Resveratrol induces vasorelaxation of mesenteric and uterine arteri mai nā wahine puaʻa puaʻa. ʻO Clin Sci (Lond) 2000; 98: 537-543. Nānā kiʻi ʻole.
139. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., a me Sacchettini, J. C. Hoʻolālā kūpono o nā mea kūpikipiki amyloid transthyretin kanaka ikaika. Nat Struct.Biol. 2000; 7: 312-321. Nānā kiʻi ʻole.
140. ʻO Martinez, J. a me Moreno, J. J. Ka hopena o resveratrol, kahi hui polyphenolic kūlohelohe, ma nā ʻano oxygen reactive a me ka hana prostaglandin. ʻO Biochem. Farmarmol 4-1-2000; 59: 865-870. Nānā kiʻi ʻole.
141. Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., a me Dannenberg, A. J. Resveratrol e kāpae i ka transclooxygenase-2 transcription i nā mammary epithelial cells. Ann.N.Y.Acad.Sci. 1999; 889: 214-223. Nānā kiʻi ʻole.
142. ʻO Dobrydneva, Y., Williams, R. L., a me Blackmore, P. F. trans-Resveratrol e kāohi i ke komo ʻana o ka calcium i loko o nā platelet kanaka i hoʻoulu ʻia e thrombin. ʻO Br.J.Farmacol. 1999; 128: 149-157. Nānā kiʻi ʻole.
143. ʻO Ciolino, H. P. a me Yeh, G. C. Kaohi ʻana i ka aryl hydrocarbon-i hoʻokomo ʻia i ka cytochrome P-450 1A1 hana i ka enzyme a me ka ʻōlelo CYP1A1 na resveratrol. Mol.Pharmacol. 1999; 56: 760-767. Nānā kiʻi ʻole.
144. Lin, J. K. a me Tsai, S. H. Chemoprevention o ka maʻi ʻaʻai a me nā maʻi maʻi maʻi na resveratrol. Proc.Natl.Sci.Counc.Repub.China B 1999; 23: 99-106. Nānā kiʻi ʻole.
145. Zou, J. G., Huang, Y. Z., Chen, Q., Wei, E. H., Hsieh, T. C., a me Wu, J. M. Resveratrol e kāpae i ka ion ion i hoʻokomo ʻia a me azo e hoʻoliʻiliʻi hui ʻia o ka lipoprotein haʻahaʻa kanaka. ʻO Biochem.Mol.Biol.Int. 1999; 47: 1089-1096. Nānā kiʻi ʻole.
146. Rahman, I. ʻO ka holomua antioxidant therapeutic i COPD. Ther.Adv.Respir.Dis. 2008; 2: 351-374. Nānā kiʻi ʻole.
147. Kimura, Y., Okuda, H., a me Kubo, M. Nā hopena o nā stilbenes i hoʻokaʻawale ʻia mai nā mea kanu lāʻau ma ka metabolism arachidonate a me ka degranulation i nā leukositene polymorphonuclear kanaka. ʻO J Ethnopharmacol. 1995; 45: 131-139. Nānā kiʻi ʻole.
148. ʻO Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, a me Espin, JC Hoʻohālikelike i kahi huaola hua waina i loko o resveratrol e hoʻemi ana i ka LDL a me ApoB i hoʻoweliweli ʻia i ka pale mua ʻana i nā maʻi maʻi puʻuwai: he makapō kolu, he 6 mahina ka ukali, kahi placebo-kāohi ʻia. , hoʻokolohua kaulike. Mol. Nutr Meaʻai Res 2012; 56: 810-821. Nānā kiʻi ʻole.
149. ʻO Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, a me Espin, ʻO JC ka makahiki hoʻokahi e hoʻohana ana i kahi huaola huaola i loko o resveratrol e hoʻomaikaʻi ai i ke kūlana hoʻoweliweli a me ka fibrinolytic o nā mea maʻi i ka pale mua ʻana i ka maʻi maʻi maʻi maʻi ʻO Am J Cardiol. 8-1-2012; 110: 356-363. Nānā kiʻi ʻole.
150. ʻO Zern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, a me Fernandez, ML Grape polyphenols e hana i kahi hopena cardioprotective i nā wahine ma mua a ma hope o ka male ma hope o ka hoʻohaʻahaʻa plasma. lipids a hoʻoliʻiliʻi i ke koʻikoʻi oxidative. ʻO J Nutr. 2005; 135: 1911-1917. Nānā kiʻi ʻole.
151. ʻO Piver, B., Berthou, F., Dreano, Y., a me Lucas, D. ʻO ke kaohi ʻana o ka cytochrome kanaka P450 enzymes e epsilon-viniferin, ke dimer o resveratrol: hoʻohālikelike me resveratrol a me polyphenols mai nā mea inu ʻona. ʻO Life Sci. 7-18-2003; 73: 1199-1213. Nānā kiʻi ʻole.
152. de, Santi C., Pietrabissa, A., Mosca, F., a me Pacifici, G. M. Glucuronidation o resveratrol, kahi huahana kūlohelohe i loaʻa i ka hua waina a me ka waina, i ke akepaʻa kanaka. Xenobiotica 2000; 30: 1047-1054. Nānā kiʻi ʻole.
153. ʻO Rosa, F. T., Zulet, M. A., Marchini, J. S., a me Martinez, J. A. ʻO nā hui bioactive me nā hopena ma nā marka mumū i kānaka. Int J Food Sci Nutr 2012; 63: 749-765. Nānā kiʻi ʻole.
154. Chang, T. K., Chen, J., a me Lee, W. B. ʻO ka hoʻohaunaele ʻokoʻa a me ka hana ʻole ʻana o nā enzyme CYP1 kanaka e trans-resveratrol: nā hōʻike no ka hana ʻole ʻana o CYP1A2. J.Pharmacol.Exp.Ther. 2001; 299: 874-882. Nānā kiʻi ʻole.
155. Basly, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., a me Chulia, A. J. Estrogenic / antiestrogenic a me nā scavenging waiwai o (E) - a me (Z) -resveratrol. ʻO Life Sci. 1-21-2000; 66: 769-777. Nānā kiʻi ʻole.
156. Mueller SO, Simon S, Chae K, et al. Hōʻike nā Phytoestrogens a me kā lākou metabolites kanaka i nā agonistic a me nā antagonistic ʻokoʻa ma ka estrogen receptor alpha (ERalpha) a me ERbeta i nā huna kanaka. Toxicol Sci 2004; 80: 14-25. Nānā kiʻi ʻole.
157. ʻO Boocock DJ, Faust GE, Patel KR, et al. ʻO ka mahele lāʻau I hoʻonui i ka lāʻau farmokokinetic study i nā mea manawaleʻa olakino o resveratrol, kahi agena chemopreventive maʻi ʻaʻai. Ka maʻi maʻi Epidemiol Biomarkers Prev 2007; 16: 1246-52. Nānā kiʻi ʻole.
158. Lyons MM, Yu C, Toma RB, et al. ʻO Resveratrol i nā blueberry maka a hoʻomoʻa ʻia a me nā bilberry. ʻO J Agric Food Chem 2003; 51: 5867-70. Nānā kiʻi ʻole.
159. Trincheri NF, Nicotra G, Follo C, et al. Hoʻokomo ʻo Resveratrol i ka make o ka cell i nā hunaola maʻi ʻaʻai kala e kekahi ala hou e pili ana i ka cathepsin lysosomal D. Carcinogenesis 2007; 28: 922-31. Nānā kiʻi ʻole.
160. Scarlatti F, Sala G, Somenzi G, et al. Hoʻokomo ʻo Resveratrol i ka pāpā ʻana i ka ulu a me apoptosis i nā hunaola maʻi ʻaʻai umauma metastatic ma o de novo ceramide signaling. FASEB J 2003; 17: 2339-41. Nānā kiʻi ʻole.
161. Wang Q, Li H, Wang XW, et al. Paipai ʻo Resveratrol i ka hoʻokaʻawale a hoʻokomo i ka apoptosis kūʻokoʻa Fas o nā hunaola medulloblastoma kanaka. Neurosci Lett 2003; 351: 83-6. Nānā kiʻi ʻole.
162. Culpitt SV, Rogers DF, Fenwick PS, et al. ʻO ka pāpā ʻia e ka ʻula waina ʻulaʻula, resveratrol, o ka cytokine e hoʻokuʻu ʻia e alveolar macrophages i COPD. ʻO Thorax 2003; 58: 942-6. Nānā kiʻi ʻole.
163. Pervaiz S. Resveratrol: mai nā hua waina i ka biology mammalian. FASEB J 2003; 17: 1975-85. Nānā kiʻi ʻole.
164. Savaskan E, Olivieri G, Meier F, et al. Pale ka mea ʻulaʻula i ka resveratrol mai beta-amyloid neurotoxicity. Gerontology 2003; 49: 380-3. Nānā kiʻi ʻole.
165. ʻO Gao X, Deeb D, Media J, et al. ʻO ka hana Immunomodulatory o resveratrol: hoʻokaʻawale i ka vitro a me nā hopena immunological vivo. ʻO Biochem Pharmacol 2003; 66: 2427-35. Nānā kiʻi ʻole.
166. ʻO Schriever C, Pendland SL, Mahady GB. ʻO ka waina ʻulaʻula, resveratrol, Chlamydia pneumoniae a me ka pili Palani. Atherosclerosis 2003; 171: 379-80. Nānā kiʻi ʻole.
167. Ziegler CC, Rainwater L, Whelan J, McEntee MF. ʻAʻole pili ka resveratrol meaʻai i ka tumigenesis ʻōpū i nā ʻiole Apc (Min / +). ʻO J Nutr 2004; 134: 5-10. Nānā kiʻi ʻole.
168. Kim YA, Choi BT, Lee YT, et al. Hoʻopilikia ʻo Resveratrol i ka hoʻonui ʻana o ka cell a hoʻokomo i ka apoptosis o nā kino kanaka umauma MCF-7. ʻO Oncol Rep 2004; 11: 441-6. Nānā kiʻi ʻole.
169. Zhang Y, Jayaprakasam B, Seeram NP, et al. ʻO ka insulin insulin a me ka cyclooxygenase enzyme i kāohi ʻia e cabernet sauvignon hua waina hua hoʻohui. ʻO J Agric Food Chem 2004; 52: 228-33. Nānā kiʻi ʻole.
170. Opipari AW Jr, Tan L, Boitano AE, et al. Hoʻopili ʻia ʻo Resveratrol autophagositosis ma nā hunaola maʻi ʻaʻa ovarian. ʻOihana Res 2004; 64: 696-703. Nānā kiʻi ʻole.
171. Abou-Zeid LA, El-Mowafy AM. ʻIʻike ʻokoʻa o nā isomers resveratrol e ka receptor-alpha estrogen kanaka: nā hōʻike dynamics molekola no ka hoʻopaʻa ʻana i ka ligand stereoselective. Chirality 2004; 16: 190-5. Nānā kiʻi ʻole.
172. Meng X, Maliakal P, Lu H, et al. ʻO ka pae urinary a me ka plasma o ka resveratrol a me ka quercetin i loko o ke kanaka, nā ʻiole, a me nāʻiole ma hope o ke komo ʻana o nā hui pono a me ka wai o ka hua waina. ʻO J Agric Food Chem 2004; 52: 935-42. Nānā kiʻi ʻole.
173. Hascalik S, Celik O, Turkoz Y, et al. ʻO Resveratrol, kahi polyphenol mea ʻona ʻulaʻula, pale aku i ka hōʻino ischemia-reperfusion o nā ovaries. Gynecol Obstet Invest 2004; 57: 218-23. Nānā kiʻi ʻole.
174. ʻO Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol e kāpae i ka apoptosis i hoʻokomo ʻia e ka lāʻau i loko o nā cell leukemia kanaka ma o ka hoʻokumu ʻana i kahi milieu intracellular nonpermissive no ka make ʻana. ʻO Reser Res. 2004; 64: 1452-9. Nānā kiʻi ʻole.
175. Li W, Seifert M, Xu Y, Hock B. Ke aʻo hoʻohālikelike o nā mana estrogenic o estradiol, tamoxifen, bisphenol-A a me resveratrol me ʻelua i vitro bioassay. ʻO Environ Int 2004; 30: 329-35. Nānā kiʻi ʻole.
176. Martin AR, Villegas I, La Casa C, de la Lastra CA. ʻO Resveratrol, kahi polyphenol i loaʻa i nā hua waina, hoʻopau i ka ʻino oxidative a hoʻoulu i ka apoptosis i ka wā o ka mumū kolona i nāʻiole. ʻO Biochem Pharmacol 2004; 67: 1399-410. Nānā kiʻi ʻole.
177. Szewczuk LM, Forti L, Stivala LA, Penning TM.ʻO Resveratrol kahi peroxidase Mediated inactivator o COX-1 akā ʻaʻole ʻo COX-2: Kahi ala mekanistic i ka hoʻolālā ʻana o COX-1 mea koho koho. ʻO J Biol Chem 2004; 279: 22727-37. Nānā kiʻi ʻole.
178. Wang Z, Huang Y, Zou J, et al. Nā hopena o ka waina ʻulaʻula a me ka waina polyphenol resveratrol ma ka hōʻuluʻulu platelet i vivo a me in vitro. Int J Mol Med 2002; 9: 77-9. Nānā kiʻi ʻole.
179. Mokni M, Limam F, Elkahoui S, et al. ʻO ka hopena cardioprotective ikaika o resveratrol, kahi polyphenol waina ʻulaʻula, ma nā puʻuwai iole i kaʻawale ma hope o ka hōʻeha ischemia / reperfusion. Arch Biochem Biophys 2007; 457: 1-6. Nānā kiʻi ʻole.
180. Elmali N, Baysal O, Harma A, et al. Nā hopena o ka resveratrol i ka maʻi rumal. Hoʻonā 2007; 30: 1-6. Nānā kiʻi ʻole.
181. Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, et al. Ka hopena o resveratrol ma ka make ʻana o ka wai ʻona a me nā ʻami o ka ate i nāʻiole. BMC Gastroenterol 2006; 6: 35. Nānā kiʻi ʻole.
182. Baur JA, Pearson KJ, Kumukūʻai NL, et al. Hoʻomaikaʻi ʻo Resveratrol i ke olakino a me ke ola ʻana o nā ʻiole ma ke ʻano he calorie kiʻekiʻe. Kūlohelohe 2006; 444: 337-42. Nānā kiʻi ʻole.
183. Murias M, Handler N, Erker T, et al. ʻO nā analogs Resveratrol ma ke ʻano he mea koho cyclooxygenase-2 mea koho: synthes a me ka pilina-hana pilina. ʻO Bioorg Med Chem 2004; 12: 5571-8. Nānā kiʻi ʻole.
184. Hwang D, Fischer NH, Jang BC, et al. ʻO ka pāpā ʻana i ka ʻōlelo o cyclooxygenase inducible a me nā cytokine proinflam inflammatory e nā sesactiter sesene lactones i nā macrophages e hoʻopili me ka pāpā o nā kinase MAP. ʻO Biochem Biophys Res Commun 1996; 226: 810-8 .. Nānā i ka abstract.
185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. ʻOkoʻa nā mea anti-inflammatory Nonsteroidal i ko lākou hiki ke kāohi i ka hoʻouluulu NF-kappaB, ka pāpā ʻana i ka ʻōlelo o cyclooxygenase-2 a me cyclin D1, a me ka hoʻopau ʻana o ka ulu ʻana o ka pūpū tumole ʻO Oncogene 2004; 23: 9247-58. Nānā kiʻi ʻole.
186. ʻO Goldberg DM, Yan J, Soleas GJ. Hoʻomaʻemaʻe ʻia o ʻekolu polyphenols e pili ana i ka waina i loko o ʻekolu mau moena ʻokoʻa e nā kumuhana olakino. ʻO Clin Biochem 2003; 36: 79-87 .. Nānā i ka abstract.
187. Docherty JJ, Fu MM, Stiffler BS, et al. Resveratrol kaohi ʻana o ka herpes simplex virus replication. Antiviral Res. 1999; 43: 145-55. Nānā kiʻi ʻole.
188. ʻO Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Hana ʻo Resveratrol ma ke ʻano he agonist / antagonist huikau no nā estrogen receptor alpha a me beta. Endocrinology 2000; 141: 3657-67.
189. ʻO Piver B, Berthou F, Dreano Y, Lucas D. Kaohi ʻana i nā hana CYP3A, CYP1A a me CYP2E1 e resveratrol a me nā mea ʻulaʻula ʻole e huhū ʻole ana. ʻO Toxicol Lett 2001; 125: 83-91. Nānā kiʻi ʻole.
190. Laden BP, Porter TD. Kūpono ʻo Resveratrol i ka monooxygenase squalene kanaka. Nutr Res 2001; 21: 747-53.
191. Kozuki Y, Miura Y, Yagasaki K. Resveratrol e kāpae i ka hoʻouka ʻana o ka cell hepatoma kūʻokoʻa i kāna hana anti-proliferative. Kanaka Lett 2001; 167: 151-6. Nānā kiʻi ʻole.
192. Schneider Y, Vincent F, Duranton B, et al. ʻO ka hopena anti-proliferative o resveratrol, kahi kūlohelohe o nā hua waina a me ka waina, ma nā hunaola maʻi ʻaʻai kanaka. Kaʻu Lett 2000; 158: 85-91.
193. Jacobson JS, Troxel AB, Evans J, et al. ʻO ka hoʻāʻo ʻana o cohosh ʻeleʻele no ka mālama ʻana i nā uila wela i waena o nā wahine me ka moʻolelo o ka maʻi ʻaʻai umauma. ʻO J Clin Oncol 2001; 19: 2739-45. Nānā kiʻi ʻole.
194. ʻO Holmes-McNary M, Baldwin AS, Jr. ʻO nā waiwai Chemopreventive o trans-resveratrol e pili pū me ka pāpā ʻana i ka hoʻoulu ʻana o ka kinase IkappaB. Pākuʻi Res 2000; 60: 3477-83. Nānā kiʻi ʻole.
195. Bertelli AA, Giovannini L, Giannessi D, et al. ʻO ka hana Antiplatelet o synthetic a kūlohelohe resveratrol i ka waina ʻulaʻula. Hana Hou Int J Tissue 1995; 17: 1-3. Nānā kiʻi ʻole.
196. ʻO Gehm BD, McAndrews JM, Chien PY, Jameson JL. ʻO Resveratrol, kahi hui polyphenolic i loaʻa i nā hua waina a me ka waina, kahi agonist no ka receptor estrogen. ʻO Proc Natl Acad Sci U S A 1997; 94: 14138-43. Nānā kiʻi ʻole.
197. Carbo N, Costelli P, Baccino FM, et al. ʻO Resveratrol, kahi huahana kūlohelohe i loaʻa i ka wāina, hoʻoliʻiliʻi i ka ulu ʻana o ka tumora i kahi hoʻohālikelike tumor rat. ʻO Biochem Biophys Res Commun 1999; 254: 739-43. Nānā kiʻi ʻole.
198. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol hoʻopau i ka hoʻololi ʻana o ka cell a hoʻokomo i ka apoptosis ma o kahi ala p53-dependant. Carcinogenesis 1999; 20: 237-42. Nānā kiʻi ʻole.
199. Davy BM, Melby CL, Beske SD, et al. ʻAʻole pili kaʻai ʻana i ka oat i ka hoʻomaha hoʻomaha maʻamau a me ka hanu 24-h i ke kahe o ke koko i nā kāne me ke kahe o ke koko kiʻekiʻe i ka pae I ke kiʻekiʻe. J Nutr 2002; 132: 394-8 .. Nānā i ka abstract.
200. Chen CK, Pace-Asciak CR. ʻO ka hana Vasorelaxing o resveratrol a me quercetin i kahi aorta ʻiole i hoʻokaʻawale ʻia. ʻO Gen Pharmacol 1996; 27: 363-6. Nānā kiʻi ʻole.
201. ʻO Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma a me nā kikowaena resveratrol kikoʻī a me ka hana pharmacological. Nā lāʻau lapaʻau Exp Clin Res 1998; 24: 133-8. Nānā kiʻi ʻole.
202. Pace-Asciak CR, Hahn S, Diamandis EP, et al. ʻO ka phenolics waina ʻulaʻula trans-resveratrol a me ka quercetin ālai i ka hōʻuluʻulu platelet kanaka a me ka synthes eicosanoid: nā hopena no ka pale ʻana i nā maʻi puʻuwau coronary. ʻO Clin Chim Acta 1995; 235: 207-19. Nānā kiʻi ʻole.
203. Bertelli AA, Giovannini L, Bernini W, et al. ʻO ka hana Antiplatelet o cis-resveratrol. Nā lāʻau lapaʻau Exp Clin Res 1996; 22: 61-3. Nānā kiʻi ʻole.
204. Pace-Asciak CR, Rounova O, Hahn SE, et al. ʻO nā waina a me nā wai hua waina ma ke ʻano he modulator o ka hōʻiliʻili platelet i nā kumuhana ola kanaka. ʻO Clin Chim Acta 1996; 246: 163-82. Nānā kiʻi ʻole.
205. Jang M, Cai L, Udeani GO, et al. ʻO ka hana chemopreventive cancer o resveratrol, kahi huahana kūlohelohe i loaʻa mai nā hua waina. ʻEpekema 1997; 275: 218-20. Nānā kiʻi ʻole.
206. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: kahi mole i hiki mai ka manawa? A hala? ʻO Clin Biochem 1997; 30: 91-113. Nānā kiʻi ʻole.
207. Agri Res Svc: Kaukaʻikepili phytochemical a me ethnobotanical a Dr. www.ars-grin.gov/duke (Loaʻa ʻia 3 Nowemapa 1999).
208. ʻO ka loiloi o nā huahana kūlohelohe e nā ʻoiaʻiʻo a me nā hoʻohālikelike. Louis, MO: Wolters Kluwer Co., 1999.
209. ʻO Foster S, ʻo Tyler VE. Herba ʻoiaʻiʻo ʻo Tyler: He alakaʻi kūpono i ka hoʻohana ʻana i nā mea kanu a me nā hoʻoponopono e pili ana. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
210. Newall CA, Anderson LA, Philpson JD. Laau Lapaʻau: He alakaʻi no nā ʻoihana mālama ola. Ladana, UK: Ka Hale Paʻi Lapaʻau, 1996.
211. ʻO Tyler VE. Nā mea kanu o ke koho. Binghamton, NY: Hale Paʻi Mea Pono Mea Pono, 1994.
212. Blumenthal M, ed. ʻO ke Komikina Kelemania E Monographs: Alakaʻi Therapeutic i nā lāʻau Laʻau. Trans. S. Klein. ʻO Boston, MA: ʻAmelika Botanical Council, 1998.
213. ʻO nā monograps e pili ana i nā lāʻau lapaʻau o nā mea kanu lāʻau. Exeter, UK: ʻEpekema ʻEpekema Co-op Phytother, 1997.

Nānā hope - 09/30/2020